MedPath

Exercise therapy in people with early-stage knee osteoarthritis: a feasibility study

Completed
Conditions
knee arthrosis
knee osteoarthritis
10023213
Registration Number
NL-OMON51703
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
45
Inclusion Criteria

Patients (m/v) aged 45 years or older

1st GP consult with non-traumatic knee complaints within 12 months prior to the
search in the medical file records of the GPs

Diagnosis according NICE criteria
• >=45 years of age
• activity related knee pain
• no morning stiffness or <= 30 min

Duration of knee complaints at the time of a GP visit should be less than 12
months

Exclusion Criteria

Previous treatment with exercise therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcomes of the pilot study will be:<br /><br>1) the percentage of eligible patients recruited at GP practices during a<br /><br>12-weeks inclusion period<br /><br>2) the percentage of included (randomized and willing to participate)<br /><br>participants during 12 weeks inclusion period<br /><br>3) adherence: the number of exercise sessions followed by the participants in<br /><br>the intervention group and, if applicable, adherence to home exercises<br /><br>(measured with exercise adherence rating scale (EARS), and<br /><br>4) patient reported outcome measures at 12 weeks follow-up, including mean pain<br /><br>intensity during last month and mean pain during activity [11-point Numerical<br /><br>Rating Scale (NRS)], Patient Acceptable Symptom State (PASS), flares, Knee<br /><br>injury and Osteoarthritis Outcome Score (KOOS), Quality of life (EQ-5D),<br /><br>Patient*s Global Assessment (PGA) (related to their knee), and self-efficacy<br /><br>for exercise (SEE)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath